pujasari neoplasia week 3

Upload: phyan-hyun

Post on 15-Feb-2018

217 views

Category:

Documents


0 download

TRANSCRIPT

  • 7/23/2019 Pujasari Neoplasia Week 3

    1/42

    NEOPLASIA

    Hening P. Syahrin

    Basic Science and Fundamental of Nursing GroupFaculty of Nursing Universitas Indonesia

    2008

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

    http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/http://www.docudesk.com/
  • 7/23/2019 Pujasari Neoplasia Week 3

    2/42

    Sub topics to cover today

    The concepts of cell growth &

    differentiation

    Characteristics of benign & malign

    neoplasm Carcinogenesis & cause of cancer

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    3/42

    Cancer is the 2nd leading cause of death in US

    after cardiovascular disease

    affects all age groups, any organ, female& male

    most common site in maleprostate, in

    femalebreast results from altered cell differentiation &

    growth

    its cell growth is uncoordinated &relatively autonomous

    is not a single disease

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    4/42

    DefinitionNeoplasia: neo (new) + plasia (form)

    the process of new growth

    Neoplasm: the new growth; can be benign ormalignant

    Tumor= tumere (to swell); historically referred toany swelling, now synonymous with neoplasm

    Oncology=oncos (mass, bulk) + logos (reason);the study of neoplasia

    Oncogenesis = oncos + genesis (production); the

    causation or production of neoplasiaCancer = karkinos (crab) the common term for all

    malignant neoplasms (used more frequently in

    human)

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    5/42

    Definition it is called cancer as it has similar characteristics

    with a cancer/crab

    eg. adhere in obstinate manner like a crab,infiltrative, erosive growth that extent crab-likefeet

    some inconsistencies in classifying & naming

    suffix oma is almost always present (fromonkoma = swelling)

    naming should indicate benign vs malignant,

    mesenchymal vs epithelial plus mixed tumor: contains more than one cell

    type but they are derived from one germ layer

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    6/42

    Classification & Naming of Neoplasm

    Benign

    Mesenchymal (structuraltissue, blood vessels,lymphatics)

    - lipoma,

    - fibroma,- osteoma.

    Epithelial:

    - pituitary adenoma- hepatocellular adenoma

    Malignant

    Mesenchymal:

    - liposarcoma,

    - fibrosarcoma,

    - osteosarcoma

    Epithelial:

    - pituitary carcinoma- hepatocellular carcinoma

    PDFCreatedwith

    deskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    7/42assificatio

    nofN

    eopla

    sm

  • 7/23/2019 Pujasari Neoplasia Week 3

    8/42assificatio

    nofN

    eopla

    sm

  • 7/23/2019 Pujasari Neoplasia Week 3

    9/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    10/42

    Benign vs Malignant NeoplasmBenign, most benign tumor are: composed of well differentiated cells that closely

    resemble their normal counterparts, often

    including the same architecture arrangementeg. a uterine leiomyoma resemble uterinesmooth muscle cells

    grow as cohesive expansive masses that remainlocalized to their site of origin grow & expand slowly with comprehensive

    atrophy of adjacent parenchymal cells & many

    have a well-defined fibrous capsule formed fromthe surrounding compressed stroma fail to metastasize to distant sites

    PDFCreatedwithdeskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    11/42

    Benign vs Malignant Neoplasm

    Benign, some benign tumor:

    are spontaneously regressed

    may slowly progress to malignancy

    morphologically, may have serious, if not

    fatal, consequencesegs. tumors of brains (space-occupyinglesions), some hormone-producing tumors

    (tumor of pancreatic islet cells thatproduces insulin, causing hypoglycemia)

    PDFCreatedwithdeskPDFPDFWrite

    r-Trial::http://www

    .docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    12/42

    Benign vs Malignant Neoplasm

    Malignant tumors

    an aggressive & life-threatening tumor

    characterized by:1) anaplasia,

    2) rapid rate of growth,

    3) local invasion of tissue, &

    4) metastasis.

    there are: 1) solid tumors & 2) hematologiccancers

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    13/42

    1) Differentiation/Anaplasia anaplasia (loss of differentiation)

    characterized malignancy

    morphology anaplasia includes:

    a) pleomorphism: variation insize & shape both cells(anisocytosis) & nuclei

    (anisokaryosis)b) abnormal nuclei: large,coarsely clumped, marginalizedchromatin

    c) mitoses: increased, tripolar

    mitotic figured) loss of polarity: no a polarizedorientation

    e) single large nucleus/

    binucleated/ multinucleated

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    14/42

    2) Rate of Growth (Tumor Cell Kinetics)

    most malignant tumors grow rapidly than benignones

    the rate of tissue growth depends on 3 factors:increased number of cells that are dividing, cellsdo not die on schedule, greater ratio of dividing

    cells and resting cells (growth fraction), &decreased length of time taken for total mass ofcells to double (doubling time/Td)

    alteratered in contact inhibition (the cessation ofgrowth after a cell comes in contact with another

    cell).

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    15/42

    CellCycle

  • 7/23/2019 Pujasari Neoplasia Week 3

    16/42

    3) Local Invasion of Tissue

    extensive infiltration (invasion) & destruction ofsurrounding tissues

    besides metastasis, invasion is the most reliableindicator of malignancy

    can make complete surgical removal difficult

    (often necessitates taking wide margins) seeding of the cancer cells into body cavities

    occurs when tumor erodes these spaces

    tumor cells secret tumor-angiogenesis factors,which enables the development of new bloodvessels within tumor (angiogenesis)

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    17/42

    4) Metastasis as a development of secondary tumor in a location

    distant from primary tumor

    indicates malignancy and is what kills the majority ofhuman cancer patients

    metastatic tumor retains characteristics of the primarytumor from which they were derived possible todetermine the site of primary tumor from the cellularcharacteristics of the metastatic tumor

    occasionally, the metastatic tumor is far advanced beforethe primary tumor becomes clinically detected

    eg. tumor of the kidney is completely

    undetected/asymptomatic even when a metastatic lesionis found in the lung

    there is selectivity in organ metastasis, eg. Heart, skin &skeletal muscle are rarely as a site of metastasis

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    18/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    19/42

    Tu

    morMetas

    tasis

  • 7/23/2019 Pujasari Neoplasia Week 3

    20/42

    gnv

    sMalignan

    tNeo

    plasm

  • 7/23/2019 Pujasari Neoplasia Week 3

    21/42

    Carcinogenic agents

    1. Chemical carcinogens

    2. Oncogenic viruses

    3. Radiation carcinogenesis

    4. Chronic inflammation5. (heredity)

    PDFCreatedwithd

    eskPDFPDFWriter-Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    22/42

    Chemical Carcinogens 2-4% cancer death are associated with an exposure to

    an occupational hazard

    egs. asbestos fiberrisks of lung, laryngeal, & GI Ca;

    benzenaleukemia; herbicidenon-Hodgkinslymphoma

    many Ca are associated with lifestyle; smoking, diet,alcohol consumption

    egs. cigarette smoke contains procarcinogen &promoterrisk of lung & laryngeal cancers

    diet contains polycyclic hydrocarbons (from smokedmeat/fish or multiple reused oil), nitrosamines (from

    food/vegetables preservative), high fat & protein but lowfibers

    the effect of carcinogenic agents is dose & durationdependent. eg. duration 5-30 years after exposure.

    PDFCreatedwithd

    eskPDFPDFWriter-Trial::http://www.

    docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    23/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    24/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    25/42

    Oncogenic Virusesan oncogenic virus is

    one that can inducecancer

    virus enters a host cell,

    incorporates into hostcell DNA, & takescontrol of the cellular

    machinery for thepurpose of producingviral proteins

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    26/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    27/42

    Radiation Carcinogenesis

    through the effect of ionizing radiation

    egs in atomic bomb survivor, patients

    diagnostically exposed, industrial workers,lab scientistmalignant epitheliomas ofskin & leukemia

    the effect depends on dose, sex, age atexposure

    sunlightskin cancer, primarily in the area

    that frequently exposed; head, neck, &arms, higher incident in individual with lackof UV filtering skin pigment melanin

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    28/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    29/42

    Chronic Inflammation the generation of O2 free radicals by

    inflammatory cells,

    the regeneration of cells to replacedamaged cells at a site of chronicinflammation may result in geneticdamage progress to neoplastictransformation

    proliferating fibroblast at the chronicinflammation can secrete growth factorsthat contribute to neoplastic transformation

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    30/42

    Heredity there is a genetic predisposition for development

    of cancers ( 50 type of cancers)

    eg. Breast cancer occurs more frequently in women whose

    grandmothers, mothers, aunts, & sisters with breast malignancy

    the risk increases 50% in women age 65 whohave multiple family members with breast cancer

    2 oncongens: BRCA1 &BRCA2 have beenimplicated in a genetic susceptibility to breastcancer

    mutation of p53 tumor suppressor gene placeswomen at high risk of breast cancer in 20 or 30of age

    40% of retinoblastoma is inherited

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    31/42

    Carcinogenesis & Cause of Cancer

    as cancer is not a single diseaseit doesnot have a single cause

    occurs because interaction between multiplerisks factors (carcinogen & heredity) orrepeated exposure to a single

    carcinogenic agentall cancers result from nonlethal genetic

    changes that transform a normal cell intocancerous cell

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    32/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    33/42

    Carsinogensis/Oncogenesisis a genetic mechanism whereby normal cells are

    transformed into cancer cells

    two kinds of gene control normal cell growth & replication:

    1. growth-promoting regulatory genesprotooncogens2. growth-inhibiting regulatory genesanti-oncogenes

    (cancer supressor genes)

    these genes have been implicated as principal targets of

    genetic damage that occurs during the development ofcancer cell

    oncogenes are mutations of normal growth-regulatinggenes

    the mutation of cause proto-oncogen to change intooncogen results in unregulated cellular proliferation

    PDFCreatedwithd

    eskPDFPDFWriter

    -Trial::http://www.docudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    34/42

    Onco

    genesis

  • 7/23/2019 Pujasari Neoplasia Week 3

    35/42

    Multiple Steps of Oncogenesis

    Transformation of normal cells into cancer cells bycarcinogenic agents is a multiple process, 3 stages:

    1. initiation: the exposure of cells to appropriate doses of acarcinogenic agent that makes them susceptible to

    malignant transformationirreversible changes in thegenome

    2. Promotion: induction of unregulated accelerated growthin already initiated cells by various chemical & growth

    factorsreversible if the promoter substance isremoved

    3. Progression: the process whereby tumor cells acquiredmalignant phenotypic changes that allow invasiveness,metastatic competency, a tendency for autonomousgrowth, & increased karyotypic instability

    PDFCreatedwithdeskPDFPDFWriter

    -Trial::http://www.d

    ocudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    36/42

    Seven Cellular Traits in Neoplasm

    1. activation of oncogenesis

    2. inactivation of tumor suppressor gen

    3. evasion of apoptosis

    4. defects in DNA repair5. limitless replicative potential

    6. sustained angiogenesis

    7. ability to invade and metastasize

    PDFCreatedwithdeskPDFPDFWriter

    -Trial::http://www.d

    ocudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    37/42

    CellularTra

    itsinN

    eopla

    sm

  • 7/23/2019 Pujasari Neoplasia Week 3

    38/42

    Systemic/General Effects of Neoplasm1. impairment of function at the primary site of involvement, caused bydestruction & replacement of parenchymal tissue by neoplastic

    growth, eg. lung cancer will impair respiratory function,

    as the tumor grows & metastasizes, other body structures become

    affected2. compression of adjacent vital structures

    the growth of brain tumor can compress adjacent vital structure3. bleeding & hemorrhage, related to compression of blood vessel

    eg. colorectal cancer--blood in the stool

    4. obstruction of hollow viscera & rupture of tubular organ as a result ofexpansive growth of tumor with compression & invasion

    5. ulceration, necrosis & infection of tumor area, related to ischemiaassociated with rapid growth, with subsequent bacterial infection

    cancers may produce enzymes & metabolic toxins that destructsurrounding tissues

    PDFCreatedwithdeskPDFPDFWriter

    -Trial::http://www.d

    ocudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    39/42

    Systemic/General Effects of Neoplasm6. effusion in serous cavity, due to impaired lymph flow or erosion of

    tumor into the cavity7. pain (that does not heal is a second warning signal of cancer)--

    liberation of pain mediator by the tumor, compression, or ischemia ofthe structure

    8. cachexia; lost of muscle mass & fat store as a result from the actionof cytokines (anorexigenic) produced by tumor cell & TNF (TumorNecrosis Factor released by macrophage

    9. anemia, caused be bleeding and depression of erythrocytesproduction

    10. inappropriate hormone productioneg. uncontrolled corticosteroid production of adrenal cortex tumorproduction of hormone-like substances that are not regulated bynormal feedback mechanisms

    11. paraneoplastic syndromes; manifestation in sites that are nor

    directly affected by disease.eg. cancer may produce procoagulation factors that contribute toincreased risk of venous thrombosis

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d

    ocudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    40/42

    Staging & Grading of Tumors

    Two basic methods of classifying cancer are:1. staging according to clinical stage of the disease, &2. grading according to histologic & cellular

    characteristics of tumors.Both methods are useful to determine the course of the

    disease & to aid in selecting appropriate treatments

    1. Staging to determine progress & spread classify tumors based according to their progression

    TNM system is based on:- assessment of the size of the primary tumor (T)- involvement of regional lymph nodes (N)- presence or absence of distant metastasis (M)

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d

    ocudesk.com

  • 7/23/2019 Pujasari Neoplasia Week 3

    41/42

  • 7/23/2019 Pujasari Neoplasia Week 3

    42/42

    Staging & Grading of Tumors

    2. Grading to determine level of differentiation & number of

    mitoses

    involves microscopic examination quantify characteristic of tumors as a means of

    predicting their outcomes:- degree of differentiation

    - size of nuclei- mitotic activity- degree of vascularization

    - presence or absence of necrosis cancers classified as grade I, II, III, & IV with increasing

    anaplasia & lack of differentiation

    PDFCreatedwithdeskPDFPDFWriter-Trial::http://www.d

    ocudesk.com